EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Limitations of Serum Ferritin in Diagnosing Iron Deficiency in Inflammatory Conditions

Axel Dignass iD, Karima Farrag, Jürgen Stein iD

International Journal of Chronic Diseases · 2018 · 2018 · 1-11

DOI: 10.1155/2018/9394060 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Chronic Diseases, 2018. Verfasst von Axel Dignass und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine 1, Agaplesion Markus Hospital, Goethe University, 60431 Frankfurt am Main, Germany. Die Arbeit wurde bisher 146-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vifor Pharma.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with inflammatory conditions such as inflammatory bowel disease (IBD), chronic heart failure (CHF), and chronic kidney disease (CKD) have high rates of iron deficiency with adverse clinical consequences. Under normal circumstances, serum ferritin levels are a sensitive marker for iron status but ferritin is an acute-phase reactant that becomes elevated in response to inflammation, complicating the diagnosis. Proinflammatory cytokines also trigger an increase in hepcidin, which restricts uptake of dietary iron and promotes sequestration of iron by ferritin within storage sites. Patients with inflammatory conditions may thus have restricted availability of iron for erythropoiesis and other cell functions due to increased hepcidin expression, despite normal or high levels of serum ferritin. The standard threshold for iron deficiency (

Autor:innen und Institutionen

  • Department of Medicine 1, Agaplesion Markus Hospital, Goethe University, 60431 Frankfurt am Main, Germany.
  • Interdisciplinary Crohn Colitis Center Rhein-Main, 60594 Frankfurt am Main, Germany.
  • Department of Gastroenterology and Clinical Nutrition, DGD Clinics Sachsenhausen, 60594 Frankfurt am Main, Germany.

ORCID-Profile: Axel Dignass, Jürgen Stein

Förderung

  • Vifor Pharma

Zitieren

APA

Dignass, A., Farrag, K., & Stein, J. (2018). Limitations of Serum Ferritin in Diagnosing Iron Deficiency in Inflammatory Conditions. International Journal of Chronic Diseases, 2018, 1-11. https://doi.org/10.1155/2018/9394060

Vancouver

Dignass A, Farrag K, Stein J. Limitations of Serum Ferritin in Diagnosing Iron Deficiency in Inflammatory Conditions. International Journal of Chronic Diseases. 2018;2018:1-11. doi:10.1155/2018/9394060

BibTeX
@article{Dignass2018,
  author = {Dignass, Axel and Farrag, Karima and Stein, Jürgen},
  title = {Limitations of Serum Ferritin in Diagnosing Iron Deficiency in Inflammatory Conditions},
  journal = {International Journal of Chronic Diseases},
  year = {2018},
  volume = {2018},
  pages = {1--11},
  doi = {10.1155/2018/9394060}
}
Kostenlos starten →